Advertisement

Diabetic foot infections

      This paper is only available as a PDF. To read, Please Download here.

      Key words

      To read this article in full you will need to make a payment

      References

        • Reiber G.E.
        • Boyko E.
        • Smith D.
        Lower extremity foot ulcers and amputations in diabetes.
        in: Harris MI Cowie CC Diabetes in America. xviii. National Institutes of Health, Bethesda. MD1995: 409-427 (NIH publ. No. 95-1468)
        • American Diabetes Association
        Diabetes 1996 Vital Statistics. American Diabetes Association, Alexandria, VA1996
        • Bild D.E.
        • Selby J.V.
        • Sinnock P.
        • Browner W.S.
        • Braverman P.
        • Showstack J.A.
        Lower extremity amputation in people with diabetes: Epidemiology and prevention.
        Diabetes Care. 1989; 12: 24
        • Gibbons G.W.
        • Eliopoulos G.M.
        Infection of the diabetic foot.
        in: Kozak G.P. Campbell D.R. Frykberg R.G. Habershaw G.M. Management of Diabetic Foot Problems. W. B. Saunders, Philadelphia1995: 121
        • Reiber G.E.
        • Pecoraro R.
        • Koepsell T.D.
        Risk factors for amputation in patients with diabetes mellitus.
        Ann. Intern. Med. 1992; 117: 97
        • Pecoraro R.E.
        • Reiber G.
        • Burgess E.M.
        Pathways to diabetic limb amputation: Basis for prevention.
        Diabetes Care. 1990; 13: 513
        • Kozak G.
        • Rowbotham J.
        • Gibbons G.W.
        Diabetic foot disease: a major problem.
        in: Kozak G. Campbell D. Management of Diabetic Foot Problems. W. B. Saunders, Philadelphia1995: 1
        • Huse D.M.
        • Oster G.
        • Killen A.R.
        The economic cost of non-insulin dependent diabetes mellitus.
        JAMA. 1989; 262: 2708-2713
        • Frykberg R.G.
        Diabetic foot ulcerations.
        in: Frykberg R.G. The High Risk Foot in Diabetes Mellitus. Churcill Livingstone, New York1991: 151
        • Sapico F.L.
        • Bessman A.N.
        Diabetic foot infections.
        in: Frykberg R.G. The High Risk Foot in Diabetes Mellitus. Churchill Livingstone, New York1991: 45
        • Caputo G.M.
        • Cavanagh P.R.
        • Ulbrecht J.S.
        • Gibbons G.W.
        • Karchmer A.W.
        Assessment and management of foot disease in patients with diabetes.
        N. Engl. J. Med. 1994; 331: 854-860
        • Frykberg R.G.
        • Veves A.
        Diabetic foot infections.
        Diabetes/Metabolism Rev. 1996; 12: 255-270
        • McNeely M.
        • Boyko E.
        • Ahroni J.
        • Stensel V.
        • Reiber G.
        • Smith D.
        • Pecoraro R.
        The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration.
        Diabetes Care. 1995; 18: 216-219
        • Boulton A.J.M.
        • Hardisty C.A.
        • Betts R.P.
        • Frank C.I.
        • Worth R.C.
        • Ward J.D.
        • Duckworth T.
        Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy.
        Diabetes Care. 1983; 6: 26
        • Cterteko G.C.
        • Dhanendran M.
        • Hutton W.C.
        • LeQuesne L.P.
        Vertical forces acting on the feet of diabetic patients with neuropathic ulceration.
        Br. J. Surg. 1981; 68: 608
        • Habershaw G.M.
        • Chrzan J.S.
        Biomechanical considerations in the diabetic foot.
        in: Kozak G.P. Campbell D.R. Frykberg R.G. Habershaw G.M. Management of Diabetic Foot Problems. 2nd ed. W. B. Saunders, Philadelphia1995: 53-65
        • Veves A.
        • Murray H.J.
        • Young M.J.
        • Boulton A.J.M.
        The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study.
        Diabetologia. 1992; 35: 660-663
        • Bagdade J.
        • Koot R.
        • Bulger R.
        Impaired leukocyte function in patients with poorly controlled diabetes.
        Diabetes. 1974; 23: 9-15
        • Bagdade J.
        • Stewart M.
        • Walters E.
        Impaired granulocyte adherence: a reversible defect in host defense in patients with poorly controlled diabetes.
        Diabetes. 1978; 27: 677-681
        • Bagdade J.
        • Nielson K.
        • Bulger R.
        Reversible abnormalities in phagocyte function in poorly controlled diabetic patients.
        Am. J. Med. Sci. 1972; 263: 451-456
        • Mowat A.
        • Baum J.
        Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus.
        N. Engl. J. Med. 1971; 284: 621-627
        • Nolan C.
        • Beaty H.
        • Bagdade J.
        Impaired granulocyte bactericidal function in patients with poorly controlled diabetes.
        Diabetes. 1978; 127: 889-894
        • MacRury S.M.
        • Gemmell C.G.
        • Paterson K.R.
        • et al.
        Changes in phagocytic function with glycemic control in diabetic patients.
        J. Clin. Pathol. 1989; 42: 1143-1147
        • Repine J.
        • Clawson C.
        • Goetz F.
        Bactericidal function of neutrophils from patients with acute bacterial infections and from diabetes.
        J. Infect. Dis. 1980; 142: 869-875
        • McMahon M.
        • Bistrian B.
        Host defenses and susceptibility to infection in patients with diabetes mellitus.
        Infect. Dis. Clin. North Am. 1995; 9: 1-9
        • Nielson C.P.
        • Hindson D.A.
        Inhibition of polymorphonucelar leukocyte respiratory burst by elevated glucose concentrations in vitro.
        Diabetes. 1989; 38: 1031-1035
        • Ortmeyer J.
        • Mohsenin V.
        Glucose suppresses superoxide generation in normal neutrophils: Interference in phospholipase D activation.
        Am. J. Physiol. 1993; 264: C402-C410
        • Maridonneau B.
        • Parini I.
        • Tringale S.
        • Tauber A.
        Identification of distinct activation pathways of the human neutrophil NADPH-oxidase.
        J. Immunol. 1986; 137: 2925-2929
        • Hostetter M.K.
        • Krueger R.A.
        • Shmeting D.J.
        The biochemistry of opsonization: Central role of the reactive thioester of the third component of complement.
        J. Infect. Dis. 1984; 150: 653-661
        • Hostetter M.K.
        Handicaps to host defense: Effects of hyper-glycemia on C3 and Candida albicans.
        Diabetes. 1990; 39: 271-275
        • Rayfiel E.J.
        • Ault M.J.
        • Keusch G.T.
        • et al.
        Infection and diabetes: the case for glucose control.
        Am. J. Med. 1982; 72: 439-450
        • Baxter J.K.
        • Babineau T.J.
        • Apovian C.M.
        • et al.
        Perioperative glucose control predicts increased nosocomial infection in diabetics.
        Crit. Care Med. 1990; 18: 5707
        • Wheat J.L.
        Infection and diabetes mellitus.
        Diabetes Care. 1980; 3: 187
        • Joseph W.S.
        Treatment of lower extremity infections in diabetics.
        J. Am. Podiatr. Assoc. 1992; 82: 361
        • Louie T.J.
        • Bartlett J.G.
        • Tally F.P.
        • Gorbach S.L.
        Aerobic and anaerobic bacteria in diabetic foot ulcers.
        Ann. Intern. Med. 1976; 85: 461
        • Lipsky B.A.
        • Pecoraro R.E.
        • Wheat L.J.
        The diabetic foot: Soft tissue and bone infection.
        Infect. Dis. Clin. North Am. 1990; 4: 409-432
        • Grayson M.L.
        Diabetic foot infections. Antimicrobial therapy.
        Infect. Dis. Clin. North Am. 1995; 9: 143-159
        • Wheat L.J.
        • Allen S.D.
        • Henry M.
        • Kemek C.B.
        • Siders J.E.
        • Duebler T.
        • Fineberg N.
        • Norton J.
        Diabetic foot infections: Bacteriologic analysis.
        Arch. Intern. Med. 1986; 146: 1935
        • Bessman A.N.
        • Geiger P.J.
        • Canawati H.
        Prevalence of Coryne-bacteria in diabetic foot infections.
        Diabetes Care. 1992; 15: 1531-1533
        • Sapico F.L.
        • Witte J.L.
        • Canawati H.N.N.
        • Montgomerie J.Z.
        • Bessman A.N.
        The infected foot of the diabetic patient: Quantitative microbiology and analysis of clinical features.
        Rev. Infect. Dis. 1984; 6: S171
        • Mills J.L.
        • Beckett W.C.
        • Taylor S.M.
        The diabetic foot: Consequences of delayed treatment and referral.
        South Med. J. 1991; 84: 970
        • Leichter S.B.
        • Allweiss P.
        • Harley J.
        • Clay J.
        • Kuperstein-Chase J.
        • Sweeney G.J.
        • Kolkin J.
        Clinical characteristics of diabetic patients with serious pedal infections.
        Metabolism. 1988; 37: 22
        • Leichter J.S.B.
        • Schaefer J.C.
        • O'Brian J.T.
        New concepts in managing diabetic foot infections.
        Geriatrics. 1991; 46: 24
        • Karchmer A.W.
        • Gibbons G.W.
        Foot infections in diabetes: Evaluation and management.
        Curr. Clin. Top. Infect. Dis. 1994; 14: 1-22
        • Harkless L.B.
        • Lavery L.A.
        • Felder-Johnson K.
        Diabetic ulceration: Classification and management.
        in: Bakker K. Kruseman A.C. Nieuw-wenhuijzen The Diabetic Foot. Excerpta Medica, Amsterdam1991: 78-82
        • Meggitt B.
        Surgical management of the diabetic foot.
        Br. J. Hosp. Med. 1976; 12: 227-232
        • Wagner F.W.
        The dysvascular foot: a system for diagnosis and treatment.
        Foot Ankle. 1981; 2: 64-122
        • Jeffcoate W.J.
        • Macfralane R.M.
        • Fletcher E.M.
        The description and classification of diabetic foot lesions.
        Diabetes Med. 1993; 10: 676-679
        • Lipsky B.A.
        • Pecoraro R.E.
        • Larson S.A.
        • Hanley M.
        • Ahroni J.I.I.
        Outpatient management of uncomplicated lower-extremity infections in diabetic patients.
        Arch. Intern. Med. 1990; 150: 790
        • Sims D.
        • Keatng S.E.
        • DeVicentis A.F.
        Bacteriology of diabetic foot ulcers.
        J. Foot Surg. 1984; 23: 149-151
        • Peterson L.R.
        • Lissack L.M.
        • Canter K.
        • Fasching C.E.
        • Clabots C.
        • Gerding D.N.
        Therapy of lower extemity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease or both.
        Am. J. Med. 1989; 86: 801-808
      1. Gentry, L. O., Rodriguez-Gomez, G., Zeluff, B. J., Khoshdel, A., Price, M. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections. Am. J. Med. 87 (Suppl.6C) 57S-60S.

        • Gentry L.O.
        • Ramiez-Ronda C.H.
        • Rodriguez-Noriega E.
        • Thadepalli H.
        • del Rosal P.L.
        • Ramirez C.
        Oral ofloxacin vs. parenteral cefotaxime in the treatment of difficult skin and skin structure infections.
        Arch. Intern. Med. 1989; 149: 2579-2583
        • Tan J.S.
        • Wishnow R.M.
        • Talan D.A.
        • Duncanson F.P.
        • Norden C.W.
        Treatment of hospitalized patients with complicated skin and skin structure infections: Double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate.
        Antimicrob. Agents Chemother. 1993; 37: 1580-1586
        • Gibbons G.W.
        The diabetic foot: Amputations and drainage of infection.
        J. Vasc. Surg. 1987; 5: 791
        • Barza M.
        Imipenem: First of a new class of beta-lactam antibiotics.
        Ann. Intern. Med. 1985; 103: 552-560
        • Grayson M.L.
        • Gibbons G.W.
        • Habershaw G.M.
        • Freeman D.V.
        • Pomposelli F.B.
        • Rosenblum B.L.
        • Levin E.
        • Karchmer A.W.
        Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.
        Clin. Infect. Dis. 1994; 18: 683-693
        • McIntyre K.E.
        Control of infection in the diabetic foot; the role of microbiology, immunopathy, antibiotics, and guillotine amputation.
        J. Vasc. Surg. 1987; 5: 787
        • Scher K.S.
        • Steele F.J.
        The septic foot in patients with diabetes.
        Surgery. 1988; 104: 661
        • LoGerfo F.W.
        • Gibbons G.W.
        • Pomposelli F.B.
        • Campbell D.R.
        • Miller A.
        • Freeman D.V.
        • Quist W.C.
        Trends in the care of the diabetic foot: Expanded role of arterial reconstruction.
        Arch. Surg. 1992; 127: 617
        • Brakora M.J.
        • Sheffield P.J.
        Hyperbaric oxygen therapy for diabetic wounds.
        Clin. Podiatr. Med. Surg. 1995; 12: 105-117
        • Newman L.G.
        • Waller J.
        • Palestgro C.J.
        • Schwartz M.
        • Klein M.J.
        • Hermann G.
        • Harrington E.
        • Roman S.H.
        • Stagnaro-Green A.
        Unsuspected osteomyelitis in diabetic foot ulcers: Diagnosis and monitoring by leukocyte scanning with indium 111 oxyquinolone.
        JAMA. 1991; 266: 1246
        • Keenan A.M.
        • Tindel N.L.
        • Alavi A.
        Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques.
        Arch. Intern. Med. 1989; 149: 2262
        • Kerr R.
        • Sartoris D.J.
        • Fix C.F.
        • Resnick D.
        Imagin of the diabetic foot.
        in: Frykberg R.G. The High Risk Foot in Diabetes Mellitus. Churchill Livingstone, New York1991
        • Unger E.
        • Moldofsky P.
        • Gatenby R.
        • Harz W.
        • Broder G.
        Diagnosis of osteomyelitis by MR imaging.
        Am. J. Roentgen. 1988; 150: 605
        • LeFrock J.L.
        • Joseph W.S.
        Bone and soft tissue infections of the lower extremity in diabetics.
        Clin. Podiatr. Med. Surg. 1995; 12: 87-103
        • Bamberger D.
        • Daus G.P.
        • Gerding D.N.
        Osteomyelitis in the foot of diabetic patients: Long term results, prognostic factors, and the role of antimicrobial and surgical therapy.
        Am. J. Med. 1987; 83: 653-660
        • Frykberg R.G.
        Team approach toward lower extremity amputation prevention in diabetes.
        J. Am. Podiatr. Med. Assoc. 1997; 87: 305-312